Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update

Go back to Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update
(NASDAQ: ELOX) Delayed: 17.45 --0 (-0%)
Previous Close $17.45    52 Week High
Open $17.45    52 Week Low
Day High $17.45    P/E N/A 
Day Low $17.45    EPS
Volume